BIOMAT Database Logo BIOMAT Database Logo

Surface binding inhibitors of the SCF-KIT protein-protein interaction. 2009

David Margulies, and Yarden Opatowsky, and Steven Fletcher, and Ishu Saraogi, and Lun K Tsou, and Sourav Saha, and Irit Lax, and Joseph Schlessinger, and Andrew D Hamilton
Department of Chemistry, Yale University, New Haven, CT 06520-8107 (USA).

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D013499 Surface Properties Characteristics or attributes of the outer boundaries of objects, including molecules. Properties, Surface,Property, Surface,Surface Property
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D019009 Proto-Oncogene Proteins c-kit A protein-tyrosine kinase receptor that is specific for STEM CELL FACTOR. This interaction is crucial for the development of hematopoietic, gonadal, and pigment stem cells. Genetic mutations that disrupt the expression of PROTO-ONCOGENE PROTEINS C-KIT are associated with PIEBALDISM, while overexpression or constitutive activation of the c-kit protein-tyrosine kinase is associated with tumorigenesis. Antigens, CD117,CD117 Antigens,Receptor, Stem Cell Factor,Stem Cell Factor Receptor,c-kit Protein,c-kit Receptor,kit Proto-Oncogene Protein,p145(c-kit),CD117 Antigen,Proto-Oncogene Protein c-kit,Proto-Oncogene Protein kit,SCF Receptor,p145 c-kit,p145c-kit,Proto Oncogene Protein c kit,Proto Oncogene Protein kit,Proto Oncogene Proteins c kit,Proto-Oncogene Protein, kit,c kit Protein,c kit Receptor,c-kit, Proto-Oncogene Protein,c-kit, Proto-Oncogene Proteins,c-kit, p145,kit Proto Oncogene Protein,p145 c kit,p145c kit
D019089 Stem Cell Factor A hematopoietic growth factor and the ligand of the cell surface c-kit protein (PROTO-ONCOGENE PROTEINS C-KIT). It is expressed during embryogenesis and is a growth factor for a number of cell types including the MAST CELLS and the MELANOCYTES in addition to the HEMATOPOIETIC STEM CELLS. Mast Cell Growth Factor,Steel Factor,c-kit Ligand,kit Ligand,c kit Ligand
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory

Related Publications

David Margulies, and Yarden Opatowsky, and Steven Fletcher, and Ishu Saraogi, and Lun K Tsou, and Sourav Saha, and Irit Lax, and Joseph Schlessinger, and Andrew D Hamilton
Interaction of protein phosphatase inhibitors with membrane lipids assessed by surface plasmon resonance based binding technique.
October 2014, Chemistry and physics of lipids,
David Margulies, and Yarden Opatowsky, and Steven Fletcher, and Ishu Saraogi, and Lun K Tsou, and Sourav Saha, and Irit Lax, and Joseph Schlessinger, and Andrew D Hamilton
The Scf/Kit pathway implements self-organized epithelial patterning.
March 2021, Developmental cell,
David Margulies, and Yarden Opatowsky, and Steven Fletcher, and Ishu Saraogi, and Lun K Tsou, and Sourav Saha, and Irit Lax, and Joseph Schlessinger, and Andrew D Hamilton
SCF-KIT pathway in human epidermal melanocyte homeostasis.
July 1999, The Journal of investigative dermatology,
David Margulies, and Yarden Opatowsky, and Steven Fletcher, and Ishu Saraogi, and Lun K Tsou, and Sourav Saha, and Irit Lax, and Joseph Schlessinger, and Andrew D Hamilton
Differential regulation of gene expression in mouse spermatogonial cells after blocking c-kit-SCF interaction with RNAi.
May 2008, Journal of RNAi and gene silencing : an international journal of RNA and gene targeting research,
David Margulies, and Yarden Opatowsky, and Steven Fletcher, and Ishu Saraogi, and Lun K Tsou, and Sourav Saha, and Irit Lax, and Joseph Schlessinger, and Andrew D Hamilton
The SCF and c-kit genes in Diamond-Blackfan anemia.
April 1992, Blood,
David Margulies, and Yarden Opatowsky, and Steven Fletcher, and Ishu Saraogi, and Lun K Tsou, and Sourav Saha, and Irit Lax, and Joseph Schlessinger, and Andrew D Hamilton
Protein interaction analysis of SCF ubiquitin E3 ligase subunits from Arabidopsis.
June 2003, The Plant journal : for cell and molecular biology,
David Margulies, and Yarden Opatowsky, and Steven Fletcher, and Ishu Saraogi, and Lun K Tsou, and Sourav Saha, and Irit Lax, and Joseph Schlessinger, and Andrew D Hamilton
Inhibitors of the FcRn:IgG protein-protein interaction.
September 2009, The AAPS journal,
David Margulies, and Yarden Opatowsky, and Steven Fletcher, and Ishu Saraogi, and Lun K Tsou, and Sourav Saha, and Irit Lax, and Joseph Schlessinger, and Andrew D Hamilton
Surfing the Protein-Protein Interaction Surface Using Docking Methods: Application to the Design of PPI Inhibitors.
June 2015, Molecules (Basel, Switzerland),
David Margulies, and Yarden Opatowsky, and Steven Fletcher, and Ishu Saraogi, and Lun K Tsou, and Sourav Saha, and Irit Lax, and Joseph Schlessinger, and Andrew D Hamilton
MultiBacMam Bimolecular Fluorescence Complementation (BiFC) tool-kit identifies new small-molecule inhibitors of the CDK5-p25 protein-protein interaction (PPI).
March 2018, Scientific reports,
David Margulies, and Yarden Opatowsky, and Steven Fletcher, and Ishu Saraogi, and Lun K Tsou, and Sourav Saha, and Irit Lax, and Joseph Schlessinger, and Andrew D Hamilton
HADDOCK(2P2I): a biophysical model for predicting the binding affinity of protein-protein interaction inhibitors.
March 2014, Journal of chemical information and modeling,
Copied contents to your clipboard!